Skip to content

Dr. Joren Brassine

Active Private limited companyfounded 2023active for 3 yearsCoupure 105, 9000 GhentKBO/BCE: BE 0797.856.771

Lifetime

3 annual accounts with figures on one time axis
peak of €67,551 in 2025
€67,551▲ 125%
peak of €37,859 in 2023
€34,048▲ 270%
peak of €85,309 in 2025
€85,309▲ 66.4%
€169,263▼ 6.8%
Board1 name since 2023
1 director
Documentsfilings and deeds
05-03-2026148 days before the deadline
2025micro format
Gross margin from €30,071 to €67,551Result from €9,202 to €34,048Equity from €51,261 to €85,309

Key points

from the 2025 annual accounts

Equity

€85,309 ▲ 66.4%

Dr. Joren Brassine has made a profit in every financial year since 2023.

Turnover

≈ €150,000 estimated

The micro format states no turnover.

Liquidity

1.84 was 0.88 in 2024

Short-term debts rose from €18,766 to €19,323.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,332 companies had the same profile as Dr. Joren Brassine has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,332 companies, not a prediction for Dr. Joren Brassine. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • founderdeed of 02-02-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0797856771
Registered office moved within Ghent The registered office moved from Hubert Frère-Orbanlaan 93 bus 101, 9000 Gent to Coupure 105 bus 0301, 9000 Gent · Board meeting of 29-04-2026 · Gazette deed
Registered office moved within Ghent The registered office moved from Dampoortstraat 30 bus A, 9000 Gent to Hubert Frére Orbanlaan 93 bus 0101, 9000 Gent · Board meeting of 01-02-2024 · Gazette deed
Incorporation Founding capital of €5,000 · Founded by · appointed as director · published on 02-02-2023 · Gazette deed
All 10 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Joren Brassine Ghent €254,572 €67,551 33.5% -
Dr. Nathalie Lagasse - NKO Lokeren €272,481 €69,506 88.0% -
INTERFASE Bonheiden €266,630 €67,071 81.1% -
SONOFORTH Colfontaine €228,690 €69,996 42.4% -
CARSI Kortrijk €249,150 €73,531 74.5% -
SKINSIGHTS CLINIC Bilzen-Hoeselt €251,238 €67,202 47.8% -
BRADLYK Forest €279,922 €78,146 92.2% -

These companies have the same main activity as Dr. Joren Brassine: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €229,000 and €280,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 31-01-2023Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.341.392.6319000 Ghent, since 31-01-2023
Financial year end
31 December
Peppol
Reachable since 21-10-2026
Company details

Annual accounts 2025

€254,572▲ 9.3%
Filing
Filed on 05-03-2026, 148 days before the end of the filing period
Financials

Insights on Dr. Joren Brassine

Dr. Joren Brassine files the micro format. That format states no turnover. The gross margin rose from €48,634 in 2023 to €67,551 in 2025.

The balance sheet grew most from 2024 to 2025 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Joren Brassine

What is the company number of Dr. Joren Brassine?
The company number of Dr. Joren Brassine is 0797.856.771. The VAT number is the same number with BE in front: BE 0797.856.771.
Where is Dr. Joren Brassine based?
The registered office is at Coupure 105, 9000 Ghent.Company details
What does Dr. Joren Brassine do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Joren Brassine?
Dr. Joren Brassine is a private limited company (BV).
When was Dr. Joren Brassine founded?
Dr. Joren Brassine was founded on 31-01-2023.
Is Dr. Joren Brassine still active?
Yes, Dr. Joren Brassine is an active enterprise in the KBO register.
What is the turnover of Dr. Joren Brassine?
The turnover in financial year 2025 is about €150,000. This figure is estimated from the gross margin of €67,551 and 33 comparable companies (NACE 862). It probably lies between €110,000 and €190,000.Financials
Is Dr. Joren Brassine profitable?
In financial year 2025, Dr. Joren Brassine made a profit of €34,048.
Where can I find the annual accounts of Dr. Joren Brassine?
Dr. Joren Brassine filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Joren Brassine due?
Dr. Joren Brassine must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.